Cybin Announces Agreement With Fluence To Support Scaling Of EMBARK Training For CYB003 Phase 3 Trial
Portfolio Pulse from Benzinga Newsdesk
Cybin has announced an agreement with Fluence to support the scaling of EMBARK training for its CYB003 Phase 3 trial. Fluence will assist in the selection and training of facilitators, create supplemental video content, and provide both asynchronous and synchronous training.
September 26, 2023 | 11:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cybin's partnership with Fluence for the scaling of EMBARK training for its CYB003 Phase 3 trial could potentially enhance the trial's success rate, which may positively impact Cybin's stock.
The partnership with Fluence will provide Cybin with expertise in facilitator selection and training, which is crucial for the success of the Phase 3 trial. If the trial is successful, it could lead to regulatory approval of CYB003, which would likely increase Cybin's stock value.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100